Toll-like receptors (TLRs) (TLRs)

Toll-like receptors (TLRs) are a family of pattern recognition receptors (PRRs) that play a pivotal role in the innate immune system by detecting pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) [1: Kawai T, et al., Nat Immunol, 2010]. These receptors are expressed on various immune cells, including dendritic cells and macrophages, and are located either on the cell surface or within endosomal membranes [2: O'Neill LA, et al., Nat Rev Immunol, 2013]. Upon ligand binding, TLRs initiate signaling through adapter proteins like MyD88 and TRIF, leading to the activation of NF-kappaB and interferon regulatory factors (IRFs), which drive the production of pro-inflammatory cytokines and type I interferons [3: Medzhitov R, Nat Rev Immunol, 2001]. The concept of "synergistic pathways" refers to the therapeutic strategy of simultaneously activating multiple TLRs to produce a more potent or qualitatively distinct immune response, often used to enhance the efficacy of vaccine adjuvants and cancer immunotherapies [4: Kasturi SP, et al., Nature, 2011]. This approach aims to mimic the natural complexity of pathogen recognition, where multiple PRRs are triggered at once. While targeting TLRs offers significant therapeutic potential, challenges include managing systemic inflammatory responses and ensuring the specificity of the immune activation to avoid autoimmunity [5: Steinhagen F, et al., Hum Vaccin Immunother, 2011]. Interacting drugs include agonists like imiquimod for TLR7 and monophosphoryl lipid A for TLR4, which are used in clinical settings to treat viral infections, skin cancers, and as vaccine components [6: Hennessy EJ, et al., Nat Rev Drug Discov, 2010].

Other names

Pattern recognition receptorsTLR familyToll-like receptor signaling pathwaySynergistic TLR activationToll-like receptors – synergistic pathways

Agonism of Toll-like receptors to stimulate innate immune signaling pathways (MyD88/TRIF), leading to the production of pro-inflammatory cytokines and enhancement of adaptive immunity [3, 5].